Status:

COMPLETED

Reducing the Incidence of Nevirapine Resistance Mutations in Pregnant HIV Infected Women Who Receive Anti-HIV Drugs Prior to and After Giving Birth

Lead Sponsor:

National Institute of Allergy and Infectious Diseases (NIAID)

Collaborating Sponsors:

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

Conditions:

HIV Infections

Eligibility:

FEMALE

18+ years

Phase:

PHASE2

Brief Summary

The purpose of this study is to determine which of 3 different anti-HIV drug regimens given to HIV infected pregnant women during and after their pregnancies is most effective in reducing the incidenc...

Detailed Description

A single dose of nevirapine (SD-NVP) given to an HIV infected pregnant woman in labor followed by a single dose to her infant had been shown to be a simple and effective means of reducing mother-to-ch...

Eligibility Criteria

Inclusion

  • Inclusion Criteria for Mothers:
  • HIV infected
  • Pregnant with a viable fetus
  • Between 28 and 38 weeks of pregnancy
  • CD4 count greater than 250 cells/mm3 within 30 days prior to study entry
  • Able to receive oral ART during labor
  • Willing to use acceptable forms of contraception while on study treatment
  • Able to provide written informed consent
  • Exclusion Criteria for Mothers:
  • Known allergy or hypersensitivity to ddI, LPV, NVP, ritonavir (RTV), or ZDV
  • Any ART other than ZDV during a previous pregnancy or the current pregnancy
  • Certain medications
  • Planning to receive additional ART during the first 8 weeks postpartum
  • Planning to breastfeed
  • Unlikely to comply with postpartum study requirements, in the opinion of the investigator
  • Certain abnormal laboratory values within 30 days prior to study entry

Exclusion

    Key Trial Info

    Start Date :

    June 1 2006

    Trial Type :

    INTERVENTIONAL

    Allocation :

    ACTUAL

    End Date :

    November 1 2009

    Estimated Enrollment :

    175 Patients enrolled

    Trial Details

    Trial ID

    NCT00109590

    Start Date

    June 1 2006

    End Date

    November 1 2009

    Last Update

    November 5 2021

    Active Locations (7)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 2 (7 locations)

    1

    Bhumibol Adulyadej Hosp. CRS

    Saimai, Bangkok, Thailand, 10220

    2

    Siriraj Hospital Mahidol University CRS

    Bangkok, Bangkoknoi, Thailand, 10700

    3

    Prapokklao Hosp. CRS

    Chanthaburi, Thailand, 22000

    4

    Chiang Mai University Pediatrics-Obstetrics CRS

    Chiang Mai, Thailand, 50200